Form 4 for WST West Pharmaceutical Services
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001562180-23-001792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-21 | WST | Green Eric Mark | Pres, CEO, Dir | A - Grant | $306.68 | +14.8K | 129.7K | +13% | +$4.53M |
| D | 2023-02-23 | 2023-02-21 | WST | Green Eric Mark | Pres, CEO, Dir | A - Grant | $0.00 | +29.9K | 29.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | A | A | 14,783 | $306.68 | 129,705.09 | D | — | — | (F1) 2020 PSUs (PP19) award vesting net of taxes withheld |
| 2 | Derivative | Stock Options (Right to buy) | 2023-02-21 | A | A | 29,872 | $0.00 | 29,872 | D | $306.68 · 2024-02-21 to 2033-02-21 | 29,872 Stock Options (Right to Buy) | (F2) This award vests in four equal annual installments beginning on February 21, 2024. |